ArticleHealth science reports2025
Indirect Impact of the COVID-19 Pandemic on All-Cause Mortality and Cardiovascular Disease Among People With Diabetes Mellitus From Korea and Hong Kong: An Interrupted Time Series Analysis.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: The COVID-19 pandemic disrupted healthcare systems globally, raising concerns about its impact on the continuing care of people with chronic conditions such as diabetes mellitus (DM). However, few studies have quantified such indirect impact among individuals who were not infected by SARS-CoV-2. This study aimed to assess the pandemic's indirect impact on all-cause mortality, cardiovascular disease (CVD) diagnoses, and healthcare utilization among people with DM in Korea and Hong Kong. Methods: We conducted a retrospective, closed-cohort study of 1,226,685 individuals (926,230 from Korea; 302,455 from Hong Kong) with a documented diagnosis of DM in 2014 but without any existing cardiovascular disease (CVD) or SARS-CoV-2 infection from January 2015 to December 2021. The cohorts were followed from January 2015 to December 2021. Interrupted time series analysis was used to assess monthly changes in all-cause mortality, CVD incidence, and healthcare utilization rates during the pandemic, compared to those in the pre-pandemic period. Results: After the initial COVID-19 outbreak in February 2020, all-cause mortality did not change significantly in either location. In Hong Kong, CVD incidence significantly declined in 2020 (IRR 0.824, 95%CI 0.732-0.929) and rapidly rebounded to the pre-pandemic level in 2021 (IRR 1.049, 95%CI 0.915-1.203). In contrast, Korea showed a reversal of the pre-pandemic decline with CVD incidence increasing significantly in 2021 (IRR 1.108, 95%CI 0.996-1.015). Outpatient visits in Korea declined at the start of 2020 (IRR 0.890, 95%CI 0.826-0.958) and remained below expected levels through 2021, while Hong Kong showed no significant changes. Hospital admissions in Korea also declined significantly and did not recover. Conclusion: The outbreak disrupted healthcare utilization among people with DM, leading to a temporary decline in CVD diagnoses. In Hong Kong, CVD incidence normalized in 2021, while in Korea, the continued increase in CVD incidence may be related to sustained care disruption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.